No abstract available
MeSH terms
-
Alemtuzumab
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Monoclonal, Murine-Derived
-
Antibodies, Neoplasm / therapeutic use
-
Antineoplastic Agents / therapeutic use
-
Benzamides
-
Clinical Trials as Topic
-
Enzyme Inhibitors / therapeutic use
-
Evidence-Based Medicine*
-
Fusion Proteins, bcr-abl
-
Hematopoietic Stem Cell Transplantation
-
Humans
-
Imatinib Mesylate
-
Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
-
Piperazines / therapeutic use
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
Pyrimidines / therapeutic use
-
Rituximab
-
Transplantation, Homologous
-
Vidarabine / analogs & derivatives*
-
Vidarabine / therapeutic use
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Monoclonal, Murine-Derived
-
Antibodies, Neoplasm
-
Antineoplastic Agents
-
Benzamides
-
Enzyme Inhibitors
-
Piperazines
-
Pyrimidines
-
Alemtuzumab
-
Rituximab
-
Imatinib Mesylate
-
Protein-Tyrosine Kinases
-
Fusion Proteins, bcr-abl
-
Vidarabine
-
fludarabine